Morepen Laboratories

45.98
+0.90
(2.00%)
Market Cap
2,519.49 Cr
EPS
1.88
PE Ratio
19.58
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
100.90
52 Week low
38.55
PB Ratio
2.22
Debt to Equity
0.03
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,666.00 3,99,729.21 33.68 49,887.20 12.06 9,648 13.77 47.46
5,505.50 1,46,153.73 71.18 8,184.00 0.89 1,600 64.53 40.99
1,452.15 1,17,277.67 23.41 26,520.70 14.17 4,155 47.38 48.78
3,080.00 1,04,241.20 55.61 10,785.70 11.59 1,656 13.54 47.28
1,094.30 91,309.58 17.35 28,905.40 12.36 5,578 1.69 31.30
2,168.10 89,448.63 44.67 10,615.60 19.57 1,942 -16.38 33.38
1,953.90 89,136.44 31.45 20,141.50 19.94 1,936 38.82 44.40
878.55 88,402.69 19.97 19,831.50 13.82 3,831 29.92 45.15
30,271.70 64,325.25 48.58 6,097.20 10.80 1,201 16.01 58.42
1,102.00 64,004.34 17.97 29,559.20 17.55 3,169 -10.04 42.48
Growth Rate
Revenue Growth
19.72 %
Net Income Growth
149.61 %
Cash Flow Change
180.48 %
ROE
121.79 %
ROCE
113.54 %
EBITDA Margin (Avg.)
68.27 %

Quarterly Financial Results

Quarterly Financials
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
132
151
156
172
164
174
215
220
203
216
235
208
259
340
310
291
388
398
399
372
303
404
350
367
404
425
449
427
459
443
458
Expenses
121
130
137
154
152
157
195
197
184
198
215
188
231
305
278
256
343
353
364
350
288
374
328
348
375
388
394
375
404
394
417
EBITDA
11
20
19
18
12
17
19
23
20
18
20
21
28
36
33
35
45
45
35
22
16
30
22
19
29
37
55
53
55
49
41
Operating Profit %
7 %
13 %
12 %
10 %
7 %
10 %
8 %
10 %
10 %
7 %
7 %
9 %
10 %
9 %
10 %
11 %
11 %
11 %
8 %
5 %
5 %
7 %
6 %
4 %
7 %
8 %
11 %
11 %
11 %
10 %
8 %
Depreciation
9
8
8
10
9
10
10
11
12
8
9
9
8
8
8
7
7
7
7
7
7
7
7
7
8
8
8
10
6
2
4
Interest
1
1
1
1
0
0
0
1
0
0
1
1
0
0
1
-0
0
-9
1
1
0
1
1
1
0
1
2
1
1
1
1
Profit Before Tax
1
11
10
7
3
7
9
11
8
9
11
11
20
28
24
28
39
47
27
14
8
22
14
11
21
29
44
42
48
46
35
Tax
0
0
0
0
0
-0
0
0
0
5
0
0
0
0
0
1
8
10
6
2
3
7
5
3
6
7
12
14
12
11
9
Net Profit
1
11
10
7
3
7
9
11
8
4
11
11
19
27
24
27
31
37
22
12
6
16
9
8
15
21
32
29
36
35
27
EPS in ₹
0.03
0.25
0.23
0.15
0.05
0.16
0.20
0.23
0.17
0.09
0.24
0.25
0.43
0.60
0.53
0.59
0.68
0.83
0.48
0.27
0.12
0.33
0.15
0.16
0.29
0.42
0.63
0.54
0.71
0.65
0.49

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
489
524
538
586
615
664
858
1,070
1,111
1,293
Fixed Assets
323
297
272
264
236
216
225
252
267
307
Current Assets
115
157
192
243
300
372
527
734
756
889
Capital Work in Progress
0
0
0
0
0
0
2
14
17
25
Investments
0
0
0
0
0
1
1
0
0
1
Other Assets
167
227
267
321
379
446
631
804
827
960
Total Liabilities
489
524
538
586
615
664
858
1,070
1,111
1,293
Current Liabilities
128
167
325
340
339
351
404
457
321
402
Non Current Liabilities
74
58
18
20
23
28
30
36
37
44
Total Equity
287
300
196
226
253
284
424
578
752
847
Reserve & Surplus
78
91
106
136
163
194
291
457
651
745
Share Capital
210
210
90
90
90
90
90
96
102
102

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-0
-5
3
-1
4
4
28
-26
6
-5
Investing Activities
-32
-27
-14
-27
-13
-13
-70
-32
-47
-83
Operating Activities
51
50
41
63
17
11
51
-60
-91
73
Financing Activities
-19
-27
-24
-38
-0
6
47
66
144
5

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
May 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Aug 2024
Sept 2024
Dec 2024
Promoter
34.54 %
34.54 %
34.54 %
34.54 %
38.38 %
36.74 %
36.74 %
38.22 %
38.22 %
38.22 %
38.22 %
38.22 %
38.22 %
38.22 %
38.22 %
35.65 %
35.65 %
35.65 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
1.29 %
0.00 %
1.85 %
1.67 %
7.72 %
2.08 %
2.22 %
DIIs
2.89 %
2.03 %
1.26 %
1.16 %
1.07 %
4.07 %
4.07 %
3.60 %
3.74 %
2.93 %
2.33 %
2.28 %
2.00 %
2.15 %
2.15 %
2.90 %
1.70 %
1.64 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
Public / Retail
42.97 %
43.89 %
44.82 %
45.18 %
42.50 %
40.88 %
40.91 %
43.63 %
44.03 %
45.04 %
45.49 %
45.56 %
44.44 %
45.03 %
45.22 %
41.89 %
48.16 %
48.35 %
Others
19.60 %
19.54 %
19.38 %
19.12 %
18.05 %
18.31 %
18.29 %
14.53 %
13.99 %
13.80 %
13.95 %
12.64 %
15.33 %
12.74 %
12.74 %
11.83 %
12.41 %
12.12 %
No of Share Holders
1,65,609
2,30,611
2,44,924
2,55,155
2,60,933
2,83,547
2,87,115
2,87,370
3,06,030
3,06,150
3,01,832
3,04,001
3,04,289
3,36,019
3,48,766
3,52,839
4,30,929
4,48,361

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Corporate Action

Announcements

Intimation Of Formation Of A Step Down Subsidiary Company
Feb 19, 2025, 14:05
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Feb 12, 2025, 13:29
Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Feb 10, 2025, 18:18
Shareholder Meeting / Postal Ballot-Outcome of EGM
Feb 10, 2025, 16:25
Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 07, 2025, 11:58
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Feb 06, 2025, 19:02
Integrated Filing (Financial)
Feb 06, 2025, 18:01
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Feb 06, 2025, 17:41
Statement Of Deviation & Variation - Proceeds Of QIP Issue
Feb 06, 2025, 17:25
Announcement under Regulation 30 (LODR)-Investor Presentation
Feb 06, 2025, 14:18
Results - Q3 FY 25
Feb 06, 2025, 14:11
Board Meeting Outcome for Board Meeting Outcome For Results Q-3 FY 25
Feb 06, 2025, 14:05
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 03, 2025, 16:59
Board Meeting Intimation for Q-3 FY 2025 Results.
Feb 03, 2025, 16:49
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Jan 28, 2025, 12:17
Update On Disclosure Submitted On 12-August-2024
Jan 22, 2025, 13:33
Announcement under Regulation 30 (LODR)-Newspaper Publication
Jan 18, 2025, 12:15
Extra-Ordinary General Meeting Of The Members - To Be Held On Monday February 10 2025
Jan 17, 2025, 16:19
Outcome Of Board Meeting-Hiving Off Medical Devices Business
Jan 14, 2025, 19:04
Intimation Under Regulation 30 Of Incorporation Of A Subsidiary Company.
Jan 08, 2025, 18:35
Closure of Trading Window
Dec 30, 2024, 17:55
Disclosure under Regulation 30A of LODR
Dec 27, 2024, 19:58
Loan Agreement
Dec 18, 2024, 16:55
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Dec 10, 2024, 19:12
Disclosure under Regulation 30A of LODR
Dec 04, 2024, 18:15
Announcement under Regulation 30 (LODR)-Change in Management
Dec 03, 2024, 18:53
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Nov 22, 2024, 15:03
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Nov 19, 2024, 15:42
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Nov 13, 2024, 18:39
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Nov 12, 2024, 17:27
Announcement under Regulation 30 (LODR)-Newspaper Publication
Nov 12, 2024, 12:41
Monitoring Agency Report - QIP Issue
Nov 11, 2024, 15:53
Statement Of Deviation & Variation - Proceeds Of QIP Issue
Nov 11, 2024, 15:46
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Nov 11, 2024, 14:33
Announcement under Regulation 30 (LODR)-Investor Presentation
Nov 11, 2024, 14:31
Results - Q2 FY 25
Nov 11, 2024, 14:28
Board Meeting Outcome for Results Q-2 FY 25
Nov 11, 2024, 14:24
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Nov 08, 2024, 18:19
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Nov 06, 2024, 17:16
Board Meeting Intimation for Q2FY25 Results
Nov 06, 2024, 16:51
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Nov 06, 2024, 11:52
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Oct 23, 2024, 12:06
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Oct 18, 2024, 18:39
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Oct 16, 2024, 18:44
General Update On Disclosure Submitted On August 27, 2024.
Oct 14, 2024, 18:18
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Oct 11, 2024, 18:09
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Sep 28, 2024, 20:57
Shareholder Meeting / Postal Ballot-Outcome of AGM
Sep 28, 2024, 17:18
Announcement under Regulation 30 (LODR)-Change in Management
Sep 27, 2024, 18:28
Closure of Trading Window
Sep 27, 2024, 15:57

Company Filings to Exchanges

Technical Indicators

RSI(14)
Neutral
30.77
ATR(14)
Less Volatile
3.01
STOCH(9,6)
Neutral
39.24
STOCH RSI(14)
Neutral
73.14
MACD(12,26)
Bullish
0.28
ADX(14)
Strong Trend
49.00
UO(9)
Bearish
41.69
ROC(12)
Downtrend And Accelerating
-13.32
WillR(14)
Oversold
-86.18